Skip to content
Home/Research/9-Me-BC (9-Methyl-β-carboline)

9-Me-BC (9-Methyl-β-carboline) Research & Studies

We track 14 published, PubMed-indexed studies for 9-Me-BC (9-Methyl-β-carboline), spanning 2008 to 2022. The research below includes 12 research articles, 2 reviews.

These summaries are for educational purposes. Research findings, particularly from preclinical studies, may not translate to human outcomes. Always consult a qualified healthcare provider before making decisions based on this information.
12
Research Articles
2
Reviews

Correction to: 9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes.

Research Article
Keller S, Polanski WH, et al.|J Neural Transm (Vienna)|2022

9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes.

Research Article
Keller S, Polanski WH, et al.|J Neural Transm (Vienna)|2020

Photophysical and Photochemical Properties of Naturally Occurring normelinonine F and Melinonine F Alkaloids and Structurally Related N(2)- and/or N(9)-methyl-β-carboline Derivatives.

Research Article
Rasse-Suriani FAO, García-Einschlag FS, et al.|Photochem Photobiol|2018

Mechanisms of DNA damage by photoexcited 9-methyl-β-carbolines.

Research Article
Vignoni M, Rasse-Suriani FA, et al.|Org Biomol Chem|2013

New agents promote neuroprotection in Parkinson's disease models.

Review
Santos CM|CNS Neurol Disord Drug Targets|2012

9-Methyl-β-carboline-induced cognitive enhancement is associated with elevated hippocampal dopamine levels and dendritic and synaptic proliferation.

Research Article
Gruss M, Appenroth D, et al.|J Neurochem|2012

Good guys from a shady family.

Research Article
Gulyaeva N, Aniol V|J Neurochem|2012

Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug?

Review
Polanski W, Reichmann H, Gille G|Expert Rev Neurother|2011

Inhibition of the bioactivation of the neurotoxin MPTP by antioxidants, redox agents and monoamine oxidase inhibitors.

Research Article
Herraiz T, Guillén H|Food Chem Toxicol|2011

9-Methyl-beta-carboline has restorative effects in an animal model of Parkinson's disease.

Research Article
Wernicke C, Hellmann J, et al.|Pharmacol Rep|2010

The exceptional properties of 9-methyl-beta-carboline: stimulation, protection and regeneration of dopaminergic neurons coupled with anti-inflammatory effects.

Research Article
Polanski W, Enzensperger C, et al.|J Neurochem|2010

Singlet excited state pyridinic deprotonation of the N9-methylbetacarboline cations in aqueous sodium hydroxide solutions.

Research Article
Coronilla AS, Carmona C, et al.|J Fluoresc|2010

Ground and singlet excited state pyridinic protonation of N9-methylbetacarboline in water-N,N-dimethylformamide mixtures.

Research Article
Sánchez Coronilla A, Carmona C, et al.|J Fluoresc|2009

9-Methyl-beta-carboline up-regulates the appearance of differentiated dopaminergic neurones in primary mesencephalic culture.

Research Article
Hamann J, Wernicke C, et al.|Neurochem Int|2008